TSW
HITK

Thompson Siegel & Walmsley’s HI-TECH PHARMACAL INC HITK Stock Holding History

Thompson Siegel & Walmsley’s Portfolio HITK Stock Details HITK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-300
Closed -$13K – 686
2013
Q3 		$13K Hold
300
– – ﹤0.01% 557
2013
Q2 		$10K Buy
+300
New +$9.98K ﹤0.01% 591

Other funds holding HITK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $489M AUM 9.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Thompson Siegel & Walmsley's HITK Position: Q4 2013 in Review

Thompson Siegel & Walmsley sold out of HI-TECH PHARMACAL INC (HITK) in Q4 2013, closing a stake of 300 shares — an estimated $13K sold.

Thompson Siegel & Walmsley first reported a position in HITK in Q2 2013 and held it in 2 quarters. The position peaked at $13K in Q3 2013. 101 funds tracked by Wall St. Rank hold HITK as of Q4 2013.

  • Thompson Siegel & Walmsley reported no remaining HI-TECH PHARMACAL INC position as of Q4 2013 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 300 HI-TECH PHARMACAL INC shares in Q4 2013, an estimated $13K.
  • Thompson Siegel & Walmsley first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 2 quarters.
  • Thompson Siegel & Walmsley's HI-TECH PHARMACAL INC position peaked at $13K in Q3 2013.
  • 101 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q4 2013.

Based on Thompson Siegel & Walmsley's 13F filing for Q4 2013, filed 6 Feb 2014.